Skip to Content

Thallous chloride, tl-201 Pregnancy and Breastfeeding Warnings

Thallous chloride, tl-201 Pregnancy Warnings

Adequate reproductive studies have not been conducted in animals. It is unknown whether this drug can cause fetal harm or affect reproduction capacity when administered to a pregnant woman.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should not be used during pregnancy unless the benefit outweighs the risk to the fetus.

AU TGA pregnancy category: Not formally assigned to a pregnancy category.
US FDA pregnancy category: C

See references

Thallous chloride, tl-201 Breastfeeding Warnings

Breastfeeding is not recommended during use of this drug.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: Consideration should be given as to whether the investigation could be reasonably delayed until the mother has ceased breast feeding.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. "Product Information. Thallous Chloride Tl 201 (thallous chloride Tl-201)." GE Healthcare, Princeton, NJ.

References for breastfeeding information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. "Product Information. Thallous Chloride Tl 201 (thallous chloride Tl-201)." GE Healthcare, Princeton, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide